How to Prepare for the Journey to Acquire Funding for Your Drug Development Program

By The Editors at Uncommon Conversations,

  When it comes to drug development, creating, testing, and analyzing a market-viable idea is half the battle. The other half involves securing the required funding so that the therapy can be commercialized and brought to the masses. From tackling investor questions to working around tight government regulations, fundraising comes with its fair share of challenges. So, what does it take to secure clinical trial funding? Our latest blog explores this topic.

Read More

Setting Gene-Based Therapies into Motion

  Remarkable healthcare advancements have come through gene-based therapies, providing improved outcomes and quality of life for patients with complex and chronic genetically linked conditions. In the article, “Navigating Through Uncharted Waters,” featured in International Clinical Trials’ November issue, Worldwide Clinical Trials’ experts – Dr. Michael Murphy, Dr. deMauri Mackie, Sophie Humphrey, and Dinah Otieno – shared insight about the challenges associated with setting clinical trials into motion for gene-based therapies and best practices to address them.

Read More